Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jul;40(1):25–30. doi: 10.1111/j.1365-2125.1995.tb04530.x

Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents.

Y I Zhang 1, R H Ritchie 1, J D Horowitz 1
PMCID: PMC1365023  PMID: 8527264

Abstract

1. The extent of postextrasystolic potentiation (PESP) has been considered a useful parameter for evaluating myocardial contractile reserve in the presence of myocardial stunning or hibernation. Extent of PESP appears to reflect an interaction between myofibrillar calcium concentration and function of the contractile apparatus. However, potential for cardiovascular drugs including agents modifying adenosine 3' 5'-cyclic monophosphate concentration to influence the extent of PESP in man has not been extensively studied. 2. In 35 patients undergoing diagnostic coronary angiography, we investigated the relationship between the extrasystolic test pulse interval (ETPI) and left ventricular (LV) +dP/dtmax of a postextrasystolic contraction. The influence of three inotropically active agents on this relationship was examined following intravenous bolus injection (metoprolol, 4 mg; sotalol, 20 mg; and milrinone, 1 mg). 3. The patient group examined had predominantly preserved LV function (LVEF 67% with 95% confidence intervals 63%, 71%). In the doses utilized, all agents exerted significant effects on LV+dP/dtmax during atrial pacing: reduction of 12.3% (6.4, 18.2) for metoprolol (P < 0.0005), and 10.9% (4.2, 17.6) for sotalol (P < 0.005); and increase of 11.8% (1.3, 22.3) for milrinone (P < 0.05). 4. With the postextrasystolic interval identical to baseline pacing cycle length, postextrasystolic potentiation of LV+dP/dtmax varied inversely with ETPI. None of the three agents investigated significantly affected this relationship. 5. These results demonstrate that the extent of PESP is unaffected by 'pure' beta-adrenoceptor antagonism, (+/-)-sotalol or phosphodiesterase inhibition in man. Hence pharmacotherapy with these agents is unlikely to affect assessment of extent of PESP.

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States. Am Heart J. 1991 Jun;121(6 Pt 2):1956–1964. doi: 10.1016/0002-8703(91)90832-3. [DOI] [PubMed] [Google Scholar]
  2. Barry W. H., Levin D. C., Green L. H., Bettman M. A., Mudge G. H., Jr, Phillips D. Left heart catheterization and angiography via the percutaneous femoral approach using an arterial sheath. Cathet Cardiovasc Diagn. 1979;5(4):401–409. doi: 10.1002/ccd.1810050413. [DOI] [PubMed] [Google Scholar]
  3. Beck W., Chesler E., Schrire V. Postextrasystolic ventricular pressure responses. Circulation. 1971 Oct;44(4):523–533. doi: 10.1161/01.cir.44.4.523. [DOI] [PubMed] [Google Scholar]
  4. Bose D., Hryshko L. V., King B. W., Chau T. Control of interval-force relation in canine ventricular myocardium studied with ryanodine. Br J Pharmacol. 1988 Nov;95(3):811–820. doi: 10.1111/j.1476-5381.1988.tb11709.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Broughton A., Korner P. I. Steady-state effects of preload and afterload on isovolumic indices of contractility in autonomically blocked dogs. Cardiovasc Res. 1980 May;14(5):245–253. doi: 10.1093/cvr/14.5.245. [DOI] [PubMed] [Google Scholar]
  6. Cohn L. H., Collins J. J., Cohn P. F. Use of the augmented ejection fraction to select patients with left ventricular dysfunction for coronary revascularization. J Thorac Cardiovasc Surg. 1976 Dec;72(6):835–840. [PubMed] [Google Scholar]
  7. Cohn P. F., Angoff G. H., Sloss L. J. Noninvasively induced postextrasystolic potentiation of ischemic and infarcted myocardium in patients with coronary artery disease. Am Heart J. 1979 Feb;97(2):187–194. doi: 10.1016/0002-8703(79)90355-7. [DOI] [PubMed] [Google Scholar]
  8. Cohn P. F. Evaluation of inotropic contractile reserve in ischemic heart disease using postextrasystolic potentiation. Circulation. 1980 Jun;61(6):1071–1075. doi: 10.1161/01.cir.61.6.1071. [DOI] [PubMed] [Google Scholar]
  9. Cohn P. F., Gorlin R., Herman M. V., Sonnenblick E. H., Horn H. R., Cohn L. H., Collins J. J., Jr Relation between contractile reserve and prognosis in patients with coronary artery disease and a depressed ejection fraction. Circulation. 1975 Mar;51(3):414–420. doi: 10.1161/01.cir.51.3.414. [DOI] [PubMed] [Google Scholar]
  10. Cooper M. W. Postextrasystolic potentiation. Do we really know what it means and how to use it? Circulation. 1993 Dec;88(6):2962–2971. doi: 10.1161/01.cir.88.6.2962. [DOI] [PubMed] [Google Scholar]
  11. Di Donato M., Maioli M., Marchionni N., Barletta G. A., Fantini F. Effects of diltiazem on postextrasystolic potentiation in coronary heart disease patients. Eur Heart J. 1990 Jul;11(7):656–661. doi: 10.1093/oxfordjournals.eurheartj.a059772. [DOI] [PubMed] [Google Scholar]
  12. Drake-Holland A. J., Sitsapesan R., Herbaczynska-Cedro K., Seed W. A., Noble M. I. Effect of adrenaline on cardiac force-interval relationship. Cardiovasc Res. 1992 May;26(5):496–501. doi: 10.1093/cvr/26.5.496. [DOI] [PubMed] [Google Scholar]
  13. Dyke S. H., Cohn P. F., Gorlin R., Sonnenblick E. H. Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation. Circulation. 1974 Oct;50(4):694–699. doi: 10.1161/01.cir.50.4.694. [DOI] [PubMed] [Google Scholar]
  14. Gwathmey J. K., Slawsky M. T., Hajjar R. J., Briggs G. M., Morgan J. P. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest. 1990 May;85(5):1599–1613. doi: 10.1172/JCI114611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hamby R. I., Aintablian A., Wisoff G., Hartstein M. L. Response of the left ventricle in coronary artery disease to postextrasystolic potentiation. Circulation. 1975 Mar;51(3):428–435. doi: 10.1161/01.cir.51.3.428. [DOI] [PubMed] [Google Scholar]
  16. Katz A. M., Tada M., Kirchberger M. A. Control of calcium transport in the myocardium by the cyclic AMP-Protein kinase system. Adv Cyclic Nucleotide Res. 1975;5:453–472. [PubMed] [Google Scholar]
  17. Kerker J. P., Ruigrok T. J., Nieuwenhuijs J. H., Borst C., Meijler F. L. Post-extra systolic potentiation: influence of calcium and verapamil in rat and rabbit hearts. Eur Heart J. 1985 Jun;6(6):532–538. doi: 10.1093/oxfordjournals.eurheartj.a061899. [DOI] [PubMed] [Google Scholar]
  18. Linuma H., Kato K. The effects of extracellular potassium and several drugs on the premature action potential and postextrasystolic potentiation. Eur J Cardiol. 1978 Jul;7(5-6):465–477. [PubMed] [Google Scholar]
  19. Mörner S. E., Arlock P. Mechanical and electrophysiological effects of milrinone on the force-frequency relationship in mammalian myocardium. Acta Physiol Scand. 1994 Feb;150(2):125–132. doi: 10.1111/j.1748-1716.1994.tb09669.x. [DOI] [PubMed] [Google Scholar]
  20. Mörner S. E., Wohlfart B. Inotropic mechanisms of amrinone in papillary muscles from guinea-pig hearts. Acta Physiol Scand. 1990 Aug;139(4):575–581. doi: 10.1111/j.1748-1716.1990.tb08961.x. [DOI] [PubMed] [Google Scholar]
  21. Mörner S. E., Wohlfart B. Myocardial force interval relationships: influence of external sodium and calcium, muscle length, muscle diameter and stimulation frequency. Acta Physiol Scand. 1992 Aug;145(4):323–332. doi: 10.1111/j.1748-1716.1992.tb09372.x. [DOI] [PubMed] [Google Scholar]
  22. Nesto R. W., Cohn L. H., Collins J. J., Jr, Wynne J., Holman L., Cohn P. F. Inotropic contractile reserve: a useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol. 1982 Jul;50(1):39–44. doi: 10.1016/0002-9149(82)90006-6. [DOI] [PubMed] [Google Scholar]
  23. Phillips P. J., Gwathmey J. K., Feldman M. D., Schoen F. J., Grossman W., Morgan J. P. Post-extrasystolic potentiation and the force-frequency relationship: differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure. J Mol Cell Cardiol. 1990 Jan;22(1):99–110. doi: 10.1016/0022-2828(90)90975-8. [DOI] [PubMed] [Google Scholar]
  24. Scognamiglio R., Fasoli G., Nistri S., Miorelli M., Frigato N., Palisi M., Miraglia G., Dalla-Volta S. Silent ischemia and loss of reversible myocardial dysfunction following myocardial infarction. Clin Cardiol. 1993 Sep;16(9):654–659. doi: 10.1002/clc.4960160906. [DOI] [PubMed] [Google Scholar]
  25. See J. R., Cohn P. F., Holman B. L., Adams D. F., Maddox D. E. Significance of reduced regional myocardial blood flow in asynergic areas evaluated with intervention ventriculography. Results of studies combining washout of xenon-133 and postextrasystolic potentiation. Am J Cardiol. 1979 Feb;43(2):179–185. doi: 10.1016/s0002-9149(79)80002-8. [DOI] [PubMed] [Google Scholar]
  26. Seed W. A., Noble M. I., Walker J. M., Miller G. A., Pidgeon J., Redwood D., Wanless R., Franz M. R., Schoettler M., Schaefer J. Relationships between beat-to-beat interval and the strength of contraction in the healthy and diseased human heart. Circulation. 1984 Nov;70(5):799–805. doi: 10.1161/01.cir.70.5.799. [DOI] [PubMed] [Google Scholar]
  27. Seed W. A., Walker J. M. Review: Relation between beat interval and force of the heartbeat and its clinical implications. Cardiovasc Res. 1988 May;22(5):303–314. doi: 10.1093/cvr/22.5.303. [DOI] [PubMed] [Google Scholar]
  28. Suko J., Ueba Y., Chidsey C. A. Intracellular calcium and myocardial contractility. II. Effects of postextrasystolic potentiation in the isolated rabbit heart. Circ Res. 1970 Aug;27(2):227–234. doi: 10.1161/01.res.27.2.227. [DOI] [PubMed] [Google Scholar]
  29. Wier W. G., Yue D. T. Intracellular calcium transients underlying the short-term force-interval relationship in ferret ventricular myocardium. J Physiol. 1986 Jul;376:507–530. doi: 10.1113/jphysiol.1986.sp016167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yue D. T., Burkhoff D., Franz M. R., Hunter W. C., Sagawa K. Postextrasystolic potentiation of the isolated canine left ventricle. Relationship to mechanical restitution. Circ Res. 1985 Mar;56(3):340–350. doi: 10.1161/01.res.56.3.340. [DOI] [PubMed] [Google Scholar]
  31. der Werf T., van Poelgeest R., Herbschleb H. H., Meijler F. L. Postextrasystolic potentiation in man. Eur J Cardiol. 1976 May;4 (Suppl):131–141. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES